InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by KOCH KEVIN. Officer active across 1 company, notably Edgewise Therapeutics, Inc.. In total, 5 disclosures have been recorded. History available since 1 May 2023. The latest transaction was disclosed on 1 May 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
5 of 5 declarations